Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies

Psychiatry Research - Neuroimaging

Volumn 174, Issue 1, 2009, Pages 76-80

  Kobayashi, Seiju ^a   Tateno, Masaru ^a   Morii, Hidetoshi ^b   Utsumi, Kumiko ^b   Saito, Toshikazu ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b SUNAGAWA CITY MEDICAL CENTER   (Japan)

Author keywords

123I metaiodobenzylguanidine; Dementia; Dementia with Lewy bodies; Myocardial scintigraphy; Orthostatic hypotension

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; ARTICLE; AUTONOMIC DENERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; DIFFUSE LEWY BODY DISEASE; DRUG UPTAKE; FEMALE; HEART INNERVATION; HEART SCINTISCANNING; HUMAN; MALE; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYMPATHETIC INNERVATION; SYMPTOM;

3-IODOBENZYLGUANIDINE; AGED; AGED, 80 AND OVER; FEMALE; HEART; HUMANS; LEWY BODY DISEASE; MALE; RADIOPHARMACEUTICALS;

EID: 71849084137     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2009.02.006     Document Type: Article

References (34)

1. Algotsson A., Viitane M., Winblad B., and Solders G. Autonomic dysfunction in Alzheimer's disease. Acta Neurologica Scandinavica 91 (1995) 14-18
2. Ballard C., Shaw F., McKeith I., and Kenny R. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 51 (1998) 1760-1762
3. Braune S., Reinhardt M., Schnitzer R., Riedel A., and Lucking C.H. Cardiac uptake of [123 I]MIBG separates Parkinson's disease from multiple system atrophy. Neurology 53 (1999) 1020-1025
4. Braune S. The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clinical Autonomic Research 11 (2001) 351-355
5. Estorch M., Camacho V., Paredes P., Rivera E., Rodríguez-Revuelto A., Flotats A., Kulisevsky J., and Carrio I. Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life. European Journal of Nuclear Medicine and Molecular Imaging 35 (2008) 1636-1641
6. Ganguly P.K., Beamish R.E., Dhalla K.S., Innes I.R., and Dhalla N.S. Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. American Journal of Physiology 252 (1987) E734-739
7. Gill J.S., Hunter G.J., Gane G., and Camm A.J. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine123-labeled meta-iodobenzylguanidine scintigraphy. American Heart Journal 126 (1993) 390-398
8. Hanyu H., Shimizu S., Hirao K., Sakurai H., Iwamoto T., Chikamori T., Hida S., Yamashina A., Koizumi K., and Abe K. The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic. Dementia and Geriatric Cognitive Disorders 22 (2006) 379-384
9. Hanyu H., Shimizu S., Hirao K., Kanetaka H., Iwamoto T., Chikamori T., Usui Y., Yamashina A., Koizumi K., and Abe K. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 33 (2006) 248-253
10. Henderson E.B., Kahn J.K., Corbett J.R., Jansen D.E., Pippin J.J., Kulkarni P., Ugolini V., Akers M.S., Hansen C., and Buja L.M. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 78 (1988) 1192-1199
11. Horimoto Y., Matsumoto M., Akatsu H., Ikari H., Kojima K., Yamamoto T., Otsuka Y., Ojika K., Ueda R., and Kosaka K. Autonomic dysfunction in dementia with Lewy bodies. Journal of Neurology 250 (2003) 530-533
12. Kobayashi S., Tateno M., Utsumi K., Takahashi A., Saitoh M., Morii H., Fujii K., and Teraoka M. Quantitative analysis of brain perfusion spect in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT. Journal of the Neurological Sciences 264 (2008) 27-33
13. Kosaka K. Diffuse Lewy body disease in Japan. Journal of Neurology 237 (1990) 197-204
14. Kuzuhara S., and Yoshimura M. Clinical and neuropathological aspects of diffuse Lewy body disease in the elderly. Advances in Neurology 60 (1993) 464-469
15. Lipsitz L.A. Orthostatic hypotension in the elderly. The New England Journal of Medicine 321 (1989) 952-957
16. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M., and Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65 (2005) 1863-1872
17. Merlet P., Valette H., Dubois-Randé J.L., Moyse D., Duboc D., Dove P., Bourguignon M.H., Benvenuti C., Duval A.M., and Agostini D. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. The Journal of Nuclear Medicine 33 (1992) 471-477
18. Minardo J.D., Tuli M.M., Mock B.H., Weiner R.E., Pride H.P., Wellman H.N., and Zipes D.P. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation, 78 (1988) 1008-1019
19. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43 (1993) 2412-2414
20. Nakajima K., Taki J., Tonami N., and Hisada K. Decreased 123I-MIBG uptake and increased clearance in various cardiac diseases. Nuclear Medicine Communications 15 (1994) 317-323
21. Orimo S., Ozawa E., Nakade S., Sugimoto T., and Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 67 (1999) 189-194
22. Orimo S., Amino T., Itoh Y., Takahashi A., Kojo T., Uchihara T., Tsuchiya K., Mori F., Wakabayashi K., and Takahashi H. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathologica 109 (2005) 583-588
23. Stanton M.S., Tuli M.M., Radtke N.L., Heger J.J., Miles W.M., Mock B.H., Burt R.W., Wellman H.N., and Zipes D.P. Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. Journal of the American College of Cardiology 14 (1989) 1519-1526
24. Suzuki M., Kurita A., Hashimoto M., Fukumitsu N., Abo M., Ito Y., Urashima M., and Inoue K. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease. Journal of the Neurological Sciences 240 (2006) 15-19
25. Taki J., Yoshita M., Yamada M., and Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Annals of Nuclear Medicine 18 (2004) 453-461
26. Tateno M., Utsumi K., Kobayashi S., Takahashi A., Saitoh M., Morii H., Fujii K., and Teraoka M. Usefulness of a blood flow analyzing program 3DSRT to detect occipital hypoperfusion in dementia with Lewy bodies. Progress in Neuropsychopharmacology and Biology Psychiatry 32 (2008) 1206-1209
27. Tateno M., Kobayashi S., Utsumi K., Morii H., and Fujii K. Quantitative analysis of the effects of donepezil on regional cerebral blood flow in Alzheimer's disease by using an automated program, 3DSRT. Neuroradiology 50 (2008) 723-727
28. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46 (1996) 1470
29. Tobes M.C., Jaques Jr. S., Wieland D.M., and Sisson J.C. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. The Journal of Nuclear Medicine 26 (1985) 897-907
30. Wieland D.M., Brown L.E., Rogers W.L., Worthington K.C., Wu J.L., Clinthorne N.H., Otto C.A., Swanson D.P., and Beierwaltes W.H. Myocardial imaging with a radioiodinated norepinephrine storage analog. The Journal of Nuclear Medicine 22 (1981) 22-31
31. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. Journal of the Neurological Sciences 155 (1998) 60-67
32. Yoshita M., Hayashi M., and Hirai S. Decreased myocardial accumulation of 123I-meta-iodobenzylguanidine in Parkinson's disease. Nuclear Medicine Communications 19 (1998) 137-142
33. Yoshita M., Taki J., and Yamada M. A clinical role for [(123I)] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. Journal of Neurology, Neurosurgery, and Psychiatry 71 (2001) 583-588
34. Yoshita M., Taki J., Yokoyama K., Noguchi-Shinohara M., Matsumoto Y., Nakajima K., and Yamada M. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 66 (2006) 1850-1854